Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check7 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Study Documents section.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata update with no visible changes to core content.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision badge updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check101 days agoChange DetectedRevision: v3.3.4 was added replacing v3.3.3; this is a minor metadata update that does not affect the study content or presentation; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.